查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606693

去氨加壓素市場：按形式、銷售管道和最終用戶分類 - 2025-2030 年全球預測

Desmopressin Market by Form (Injectable Solution, Nasal Spray, Tablet), Sales Channel (Offline, Online), End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年去氨加壓素市場估值為12.5億美元，預計到2024年將達到13億美元，預計到2030年將以6.68%的複合年成長率成長至19.7億美元。

去氨加壓素是抗利尿激素增壓素的合成類似物，主要用於治療多種疾病，包括糖尿病性尿崩症、尿床和出血性疾病，如馮·維勒布蘭德病和輕度形式的A型血友病了解去氨加壓素的必要性在於它在保水和凝血過程中的有效作用，這使得它在需要精確液體平衡和凝血調節的醫療環境中至關重要。去氨加壓素可用於醫院、診所和家庭保健，並以錠劑、注射和滴鼻劑的形式給藥。最終用途主要在醫療機構內，也有可能在嚴格的醫療指導下用於家庭使用。根據市場洞察，主要的成長動力是中樞性糖尿病主訴等疾病的盛行率增加、對出血性疾病的認知提高以及藥物傳遞系統的進步。人口老化和夜間遺尿發生率上升導致需求不斷增加。然而，諸如低鈉血症（低血鈉水平）等副作用、藥物核准的監管障礙以及高治療成本等挑戰限制了市場成長潛力。機會包括遞送機制的持續創新，包括新型滴鼻劑和舌下片等非侵入性劑型，以及將應用擴展到新的治療領域。利用這些機會的建議包括投資於研究和開發，以提高製劑的效率和安全性，利用戰略夥伴關係進行市場擴張，以及提高新興市場對該疾病的認知，這包括將行銷工作集中在以下方面。潛在副作用和替代療法的競爭等挑戰仍然很困難，但透過改進配方和具有成本效益的解決方案來解決這些挑戰可以提高競爭力。創新領域應重點關注治療方法的最佳化以及未滿足的關鍵字在醫療需求未滿足的其他疾病的治療中的使用。市場的本質是動態的，需要不斷適應監管變化和不斷變化的醫療保健需求。

主要市場統計
基準年[2023] 12.5億美元
預測年份 [2024] 13億美元
預測年份 [2030] 19.7億美元
複合年成長率（%） 6.68%

市場動態：揭示快速發展的去氨加壓素市場的關鍵市場洞察

供需的動態交互作用正在改變去氨加壓素市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球糖尿病患者數量不斷增加
    • 支持糖尿病意識和治療的政府措施和計劃
  • 市場限制因素
    • 與去氨加壓素相關的副作用
  • 市場機會
    • 繼續新配方的研發活動
    • 去氨加壓素的監管核准增加
  • 市場挑戰
    • 替代藥物的可用性

波特的五力：駕馭去氨加壓素市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解去氨加壓素市場的外部影響

外部宏觀環境因素在塑造去氨加壓素市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解去氨加壓素市場的競爭狀況

對去氨加壓素市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣去氨加壓素市場供應商的績效評估

FPNV定位矩陣是評估去氨加壓素市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了去氨加壓素市場的成功之路

去氨加壓素市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球尿崩症患者數量不斷增加
      • 支持糖尿病意識和治療的政府措施和計劃
    • 抑制因素
      • 與去氨加壓素相關的不良反應
    • 機會
      • 新配方的持續研發活動
      • 去氨加壓素的監管核准增加
    • 任務
      • 替代醫學的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 去氨加壓素市場：依形式

  • 注射液
  • 鼻噴劑
  • 錠劑

第7章去氨加壓素市場：依銷售管道

  • 離線
  • 線上

第 8 章 去氨加壓素市場：依最終用戶分類

  • 居家護理
  • 醫院
  • 專科診所

第9章 美洲去氨加壓素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區去氨加壓素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲去氨加壓素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AA Pharma Inc.
  • Amring Pharmaceuticals Inc.
  • Antares Pharma, Inc. by Halozyme, Inc.
  • Apotex Inc.
  • Avadel Pharmaceuticals PLC
  • Bachem AG
  • BluePoint Laboratories
  • CSC Pharmaceuticals International
  • Dr. Reddy's Laboratories Ltd.
  • Enomark
  • Ferring Pharmaceuticals
  • Glenmark Pharmaceuticals Limited
  • Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
  • KVR Pharmaceuticals
  • Manus Aktteva Biopharma LLP
  • Midas Pharma GmbH
  • NorthStar Rx LLC
  • Pfizer Inc.
  • Ralington Pharma LLP
  • Saintroy Lifescience
  • Sanofi SA
  • Sava Healthcare Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • VIVAN Life Sciences Pvt. Limited
Product Code: MRR-C002B1C9948C

The Desmopressin Market was valued at USD 1.25 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 6.68%, to USD 1.97 billion by 2030.

Desmopressin, a synthetic analog of the antidiuretic hormone vasopressin, is primarily used to manage various medical conditions such as diabetes insipidus, bedwetting (nocturnal enuresis), and bleeding disorders like von Willebrand's disease and mild hemophilia A. Understanding the necessity of desmopressin hinges on its effective role in water retention and coagulation processes, making it vital in medical settings that require precise fluid balance and clotting regulation. The application scope of desmopressin spans hospitals, clinics, and home healthcare settings where it is administered in forms such as tablets, injectables, and nasal sprays. The end-use is mainly within healthcare facilities, with potential home use under strict medical guidance. Market insights indicate that the primary growth drivers are increasing prevalence rates of conditions like central diabetes insipidus, heightened awareness about bleeding disorders, and advancements in drug delivery systems. Aging populations and the rising incidence of nocturnal enuresis contribute to expanding the demand. However, challenges such as side effects, including hyponatremia (low blood sodium), regulatory hurdles in drug approval, and high therapy costs limit market growth potential. Opportunities abound in the ongoing innovation of delivery mechanisms, particularly non-invasive delivery forms like novel nasal sprays or sublingual tablets, and extending applications to newer therapeutic areas. Recommendations for capitalizing on these opportunities include investing in R&D to improve formulation efficiency and safety, leveraging strategic partnerships for market expansion, and focusing marketing efforts on emerging markets where disease awareness is increasing. Limitations such as potential side effects and competition from alternative therapies remain challenging; however, addressing these through improved drug formulations and cost-effective solutions could provide a competitive edge. Areas of innovation should focus on optimizing therapeutic regimens and exploring the use of desmopressin in treating other conditions with unmet medical needs. The market's nature is dynamic, necessitating continuous adaptation to regulatory changes and evolving healthcare demands.

KEY MARKET STATISTICS
Base Year [2023] USD 1.25 billion
Estimated Year [2024] USD 1.30 billion
Forecast Year [2030] USD 1.97 billion
CAGR (%) 6.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Desmopressin Market

The Desmopressin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising occurrence of diabetes insipidus in patients worldwide
    • Government initiatives and programs supporting diabetes awareness & treatment
  • Market Restraints
    • Adverse effects associated with the desmopressin
  • Market Opportunities
    • Ongoing research & development activities for new formulations
    • Increasing in regulatory approvals for desmopressin
  • Market Challenges
    • Availability of alternative medicines

Porter's Five Forces: A Strategic Tool for Navigating the Desmopressin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Desmopressin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Desmopressin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Desmopressin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Desmopressin Market

A detailed market share analysis in the Desmopressin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Desmopressin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Desmopressin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Desmopressin Market

A strategic analysis of the Desmopressin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Desmopressin Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Amring Pharmaceuticals Inc., Antares Pharma, Inc. by Halozyme, Inc., Apotex Inc., Avadel Pharmaceuticals PLC, Bachem AG, BluePoint Laboratories, CSC Pharmaceuticals International, Dr. Reddy's Laboratories Ltd., Enomark, Ferring Pharmaceuticals, Glenmark Pharmaceuticals Limited, Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey, KVR Pharmaceuticals, Manus Aktteva Biopharma LLP, Midas Pharma GmbH, NorthStar Rx LLC, Pfizer Inc., Ralington Pharma LLP, Saintroy Lifescience, Sanofi S.A., Sava Healthcare Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and VIVAN Life Sciences Pvt. Limited.

Market Segmentation & Coverage

This research report categorizes the Desmopressin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Injectable Solution, Nasal Spray, and Tablet.
  • Based on Sales Channel, market is studied across Offline and Online.
  • Based on End-Users, market is studied across Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising occurrence of diabetes insipidus in patients worldwide
      • 5.1.1.2. Government initiatives and programs supporting diabetes awareness & treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with the desmopressin
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research & development activities for new formulations
      • 5.1.3.2. Increasing in regulatory approvals for desmopressin
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative medicines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Desmopressin Market, by Form

  • 6.1. Introduction
  • 6.2. Injectable Solution
  • 6.3. Nasal Spray
  • 6.4. Tablet

7. Desmopressin Market, by Sales Channel

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. Desmopressin Market, by End-Users

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Desmopressin Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Desmopressin Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Desmopressin Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AA Pharma Inc.
  • 2. Amring Pharmaceuticals Inc.
  • 3. Antares Pharma, Inc. by Halozyme, Inc.
  • 4. Apotex Inc.
  • 5. Avadel Pharmaceuticals PLC
  • 6. Bachem AG
  • 7. BluePoint Laboratories
  • 8. CSC Pharmaceuticals International
  • 9. Dr. Reddy's Laboratories Ltd.
  • 10. Enomark
  • 11. Ferring Pharmaceuticals
  • 12. Glenmark Pharmaceuticals Limited
  • 13. Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
  • 14. KVR Pharmaceuticals
  • 15. Manus Aktteva Biopharma LLP
  • 16. Midas Pharma GmbH
  • 17. NorthStar Rx LLC
  • 18. Pfizer Inc.
  • 19. Ralington Pharma LLP
  • 20. Saintroy Lifescience
  • 21. Sanofi S.A.
  • 22. Sava Healthcare Limited
  • 23. Sun Pharmaceutical Industries Limited
  • 24. Teva Pharmaceutical Industries Ltd.
  • 25. VIVAN Life Sciences Pvt. Limited

LIST OF FIGURES

  • FIGURE 1. DESMOPRESSIN MARKET RESEARCH PROCESS
  • FIGURE 2. DESMOPRESSIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DESMOPRESSIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DESMOPRESSIN MARKET DYNAMICS
  • TABLE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DESMOPRESSIN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DESMOPRESSIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DESMOPRESSIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 145. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023